Patients | TC mmol/l | HDLc mmol/l | LDLc mmol/l |
---|---|---|---|
Gender T-test | 0.05 | 0.19 | 0.12 |
Tanner stage (≤4 or = 5) T-test | 0.87 | 0.51 | 0.85 |
Subgroup of JIA ANOVA | 0.05 | 0.85 | 0.09 |
Treatment a ANOVA | 0.83 | 0.68 | 0.98 |
Disease duration Bivariate correlation | 0.93 | 0.19 | 0.84 |
Primary endpoints: | |||
MRP 8/14 Bivariate correlation, p value Pearson correlation coefficient, r 95 % confidence interval | 0.20 | <0.0005* −0.343 (−0.474 to −0.201) | 0.92 |
CRP Bivariate correlation, p value Pearson correlation coefficient, r 95 % confidence interval | 0.83 | 0.043 −0.167 (−0.319 to–0.015) | 0.63 |
JADAS 27 b Nonparametric correlation | 0.66 | 0.72 | 0.92 |
Waist-to-height ratio Bivariate correlation, p value Pearson correlation coefficient r 95 % confidence interval | 0.824 | 0.018 −0.187 (−0.345 to–0.033) | 0.199 |
BMI SDS Bivariate correlation | 0.15 | 0.13 | 0.49 |
Counts per minute (cpm) (133 patients) Bivariate correlation | 0.23 | 0.25 | 0.33 |
Sedentary time (minutes/day) (133 patients) Bivariate correlation | 0.23 | 0.61 | 0.11 |
High activity (minutes/day) (133 patients) Bivariate correlation | 0.15 | 0.21 | 0.17 |